First humans receive experimental drug ORKA-002 in safety trial
NCT ID NCT06944379
Summary
This is the first study to give the experimental drug ORKA-002 to people. Its main purpose is to check if it is safe and to see how the body processes it. The study will involve about 24 healthy volunteers who will receive a single injection. Researchers will carefully monitor participants for any side effects and measure drug levels in their blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Oruka Therapeutics Investigative Site
Christchurch, New Zealand, New Zealand
Conditions
Explore the condition pages connected to this study.